Sunitinib maleate administration before percutaneous CT-guided cryoablation for large renal cell carcinoma: A case report

A 60-year-old woman taking anti-platelet drugs was referred to the hospital for the treatment of advanced renal cell carcinoma. CT revealed that the tumor had a diameter of 5 cm and hyper-vascularity. Percutaneous CT-guided cryoablation (CA) was indicated. Since preprocedural arterial embolization f...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishizawa, Kaori, Katsumori, Tetsuya, Kotera, Yuya, Yoshikawa, Tatsuya, Nishimura, Tomoaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552030/
https://www.ncbi.nlm.nih.gov/pubmed/36238214
http://dx.doi.org/10.1016/j.radcr.2022.09.047
_version_ 1784806167088726016
author Nishizawa, Kaori
Katsumori, Tetsuya
Kotera, Yuya
Yoshikawa, Tatsuya
Nishimura, Tomoaki
author_facet Nishizawa, Kaori
Katsumori, Tetsuya
Kotera, Yuya
Yoshikawa, Tatsuya
Nishimura, Tomoaki
author_sort Nishizawa, Kaori
collection PubMed
description A 60-year-old woman taking anti-platelet drugs was referred to the hospital for the treatment of advanced renal cell carcinoma. CT revealed that the tumor had a diameter of 5 cm and hyper-vascularity. Percutaneous CT-guided cryoablation (CA) was indicated. Since preprocedural arterial embolization failed to provide sufficient embolic effects, sunitinib maleate was administered. It provided good tumor devascularization and volume reduction, which corresponded to downstage. Therefore, the administration contributed to successfully performing subsequent percutaneous CT-guided CA with no serious hemorrhagic complications. Sunitinib maleate may be an alternative to conventional treatments before CA for renal cell carcinoma.
format Online
Article
Text
id pubmed-9552030
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-95520302022-10-12 Sunitinib maleate administration before percutaneous CT-guided cryoablation for large renal cell carcinoma: A case report Nishizawa, Kaori Katsumori, Tetsuya Kotera, Yuya Yoshikawa, Tatsuya Nishimura, Tomoaki Radiol Case Rep Case Report A 60-year-old woman taking anti-platelet drugs was referred to the hospital for the treatment of advanced renal cell carcinoma. CT revealed that the tumor had a diameter of 5 cm and hyper-vascularity. Percutaneous CT-guided cryoablation (CA) was indicated. Since preprocedural arterial embolization failed to provide sufficient embolic effects, sunitinib maleate was administered. It provided good tumor devascularization and volume reduction, which corresponded to downstage. Therefore, the administration contributed to successfully performing subsequent percutaneous CT-guided CA with no serious hemorrhagic complications. Sunitinib maleate may be an alternative to conventional treatments before CA for renal cell carcinoma. Elsevier 2022-10-08 /pmc/articles/PMC9552030/ /pubmed/36238214 http://dx.doi.org/10.1016/j.radcr.2022.09.047 Text en © 2022 The Authors. Published by Elsevier Inc. on behalf of University of Washington. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Nishizawa, Kaori
Katsumori, Tetsuya
Kotera, Yuya
Yoshikawa, Tatsuya
Nishimura, Tomoaki
Sunitinib maleate administration before percutaneous CT-guided cryoablation for large renal cell carcinoma: A case report
title Sunitinib maleate administration before percutaneous CT-guided cryoablation for large renal cell carcinoma: A case report
title_full Sunitinib maleate administration before percutaneous CT-guided cryoablation for large renal cell carcinoma: A case report
title_fullStr Sunitinib maleate administration before percutaneous CT-guided cryoablation for large renal cell carcinoma: A case report
title_full_unstemmed Sunitinib maleate administration before percutaneous CT-guided cryoablation for large renal cell carcinoma: A case report
title_short Sunitinib maleate administration before percutaneous CT-guided cryoablation for large renal cell carcinoma: A case report
title_sort sunitinib maleate administration before percutaneous ct-guided cryoablation for large renal cell carcinoma: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552030/
https://www.ncbi.nlm.nih.gov/pubmed/36238214
http://dx.doi.org/10.1016/j.radcr.2022.09.047
work_keys_str_mv AT nishizawakaori sunitinibmaleateadministrationbeforepercutaneousctguidedcryoablationforlargerenalcellcarcinomaacasereport
AT katsumoritetsuya sunitinibmaleateadministrationbeforepercutaneousctguidedcryoablationforlargerenalcellcarcinomaacasereport
AT koterayuya sunitinibmaleateadministrationbeforepercutaneousctguidedcryoablationforlargerenalcellcarcinomaacasereport
AT yoshikawatatsuya sunitinibmaleateadministrationbeforepercutaneousctguidedcryoablationforlargerenalcellcarcinomaacasereport
AT nishimuratomoaki sunitinibmaleateadministrationbeforepercutaneousctguidedcryoablationforlargerenalcellcarcinomaacasereport

Ejemplares similares